Analysis of market trend of Human Albumin and Coagulation factors in India

Authors

  • Swati Shalini National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Rashmi Srivastava National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Harit Kasana Scientist Grade II, National Institute of Biologicals, (Ministry of Health and Family Welfare, Government of India), A-32, Sector-62, Noida-201 309
  • Mohit Sharma National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Swati Sharma National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Meenakshi Chaudhary National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Priyanka Gupta National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Charu Sharma National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Sandeep Rawat National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Dikamber Singh National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Kallol Saha National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309
  • Reba Chhabra National Institute of Biologicals (Ministry of Health and Family Welfare, Government of India) A-32, Sector-62, NOIDA-201 309

DOI:

https://doi.org/10.7439/ijbar.v10i10.5268

Keywords:

Human serum albumin, Factor VIII, Factor IX, Plasma fractionation products

Abstract

The present study has been conducted atNational Institute of Biologicals (NIB), NOIDA to analyse the status of Human Serum Albumin (HSA) and other human plasma derived products and their availability in Indian market. The samples of albumin, human coagulation factor VIII and factor IX, both indigenously manufactured and imported, which were received in the Institute during financial years FY 2012-13 to 2017-18.The present study showed that there was no change in the number of indigenously manufactured HSA samples received in 2013-14 and 2014-15 afterwards the data showed gradually decline in viz. of 29% in the 2015-16 and further by 84% in 2016-17.It was observed that there is a gap between supply and demand of plasma fractionation products as most of them are imported. The non-availability of quality domestic plasma fraction has led to dependence on imported plasma for production of indigenously manufactured plasma products.Strong reforms in regulations and Health Policies within the country as well as globally is the key to address the situation and achieve the target of self-sufficiency in indigenous production of plasma based medicinal products.

Downloads

Download data is not yet available.

Downloads

Published

2019-10-27

Issue

Section

Original Research Articles

How to Cite

1.
Analysis of market trend of Human Albumin and Coagulation factors in India. Int J of Biomed & Adv Res [Internet]. 2019 Oct. 27 [cited 2024 Oct. 18];10(10):e5268. Available from: https://ssjournals.co.in/index.php/ijbar/article/view/5268

Similar Articles

1-10 of 295

You may also start an advanced similarity search for this article.